Next Article in Journal
Advances in Gastroesophageal Reflux Disease Management: Exploring the Role of Potassium-Competitive Acid Blockers and Novel Therapies
Next Article in Special Issue
Model-Based Evaluation of HangAmDan-B1 and Afatinib Combination Therapy in HCC827 Xenograft Mice with Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Previous Article in Journal
Research Progress on Phytochemicals from Mulberry with Neuroprotective Effects: A Review
Previous Article in Special Issue
A Successful Experience of Individualized Vancomycin Dosing in Critically Ill Patients by Using a Loading Dose and Maintenance Dose
 
 
Systematic Review

Article Versions Notes

Pharmaceuticals 2025, 18(5), 698; https://doi.org/10.3390/ph18050698
Action Date Notes Link
article pdf uploaded. 8 May 2025 17:12 CEST Version of Record https://www.mdpi.com/1424-8247/18/5/698/pdf-vor
article supplementary file uploaded. 8 May 2025 17:12 CEST - https://www.mdpi.com/1424-8247/18/5/698#supplementary
article xml file uploaded 9 May 2025 07:59 CEST Original file -
article xml uploaded. 9 May 2025 07:59 CEST Update -
article pdf uploaded. 9 May 2025 07:59 CEST Updated version of record https://www.mdpi.com/1424-8247/18/5/698/pdf-vor
article html file updated 9 May 2025 08:01 CEST Original file -
article xml file uploaded 12 May 2025 10:03 CEST Update -
article xml uploaded. 12 May 2025 10:03 CEST Update https://www.mdpi.com/1424-8247/18/5/698/xml
article pdf uploaded. 12 May 2025 10:03 CEST Updated version of record https://www.mdpi.com/1424-8247/18/5/698/pdf
article html file updated 12 May 2025 10:05 CEST Update https://www.mdpi.com/1424-8247/18/5/698/html
Back to TopTop